PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on January 30, 2026. It represents a primary source document for Japanese Buyback sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: January 30, 2026 Carna Biosciences,Inc. [4572.T] TOKYO, Jan 30 (Pulse News Wire) – Carna Biosciences,inc. (4572.T) corrected its previous announcement regarding the repurchase and cancellation of its convertible bonds issued in July 2025. According to the revised statement, the company's board meeting held on January 29, 2026, decided to repurchase all remaining bonds as of February 17, 2026, instead of February 17, 2025, as initially stated. The initial announcem